Charles Schwab
PAVM icon

Charles Schwab’s PAVmed PAVM Stock Holding History

Charles Schwab’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-177
Closed -$23.4K – 3558
2023
Q3 		$23.4K Hold
177
– – ﹤0.01% 3498
2023
Q2 		$32.4K Buy
+177
New +$35.4K ﹤0.01% 3491
2022
Q4 		– Sell
-64
Closed -$25K – 3559
2022
Q3 		$25K Hold
64
– – ﹤0.01% 3460
2022
Q2 		$27K Sell
64
-370
-85% -$179K ﹤0.01% 3495
2022
Q1 		$258K Buy
434
+24
+6% +$17.8K ﹤0.01% 3257
2021
Q4 		$455K Buy
410
+8
+2% +$17.4K ﹤0.01% 3178
2021
Q3 		$1.54M Sell
402
-1
-0.2% -$3.15K ﹤0.01% 2755
2021
Q2 		$1.16M Buy
403
+43
+12% +$102K ﹤0.01% 2873
2021
Q1 		$719K Buy
360
+188
+109% +$283K ﹤0.01% 2956
2020
Q4 		$164K Hold
172
– – ﹤0.01% 3278
2020
Q3 		$138K Hold
172
– – ﹤0.01% 3228
2020
Q2 		$164K Buy
+172
New +$172K ﹤0.01% 3195

Other funds holding PAVM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
XF
XML Financial Bethesda, Maryland $1.24B AUM 20.4% 1-Year Est. Return

Charles Schwab's PAVM Position: Q4 2023 in Review

Charles Schwab sold out of PAVmed (PAVM) in Q4 2023, closing a stake of 177 shares — an estimated $23.4K sold.

Charles Schwab first reported a position in PAVM in Q2 2020 and held it in 12 quarters. The position peaked at $1.54M in Q3 2021. 23 funds tracked by Wall St. Rank hold PAVM as of Q4 2023.

  • Charles Schwab reported no remaining PAVmed position as of Q4 2023 after selling out during the quarter.
  • Charles Schwab sold 177 PAVmed shares in Q4 2023, an estimated $23.4K.
  • Charles Schwab first reported a position in PAVmed in Q2 2020 and held it in 12 quarters.
  • Charles Schwab's PAVmed position peaked at $1.54M in Q3 2021.
  • 23 funds tracked by Wall St. Rank held PAVmed as of Q4 2023.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.